| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | INSP | Common Stock | Sale | -$18.6M | -74.3K | -64.45% | $250.20 | 41K | Mar 29, 2022 | By family trust | F1, F2, F3, F4 |
| transaction | INSP | Common Stock | Sale | -$3.42M | -13.6K | -11.47% | $251.06 | 105K | Mar 29, 2022 | By trust | F5, F6, F7 |
| transaction | INSP | Common Stock | Sale | -$369K | -1.47K | -1.39% | $251.92 | 104K | Mar 29, 2022 | By trust | F7, F8 |
| transaction | INSP | Common Stock | Sale | -$2.02M | -8.02K | -6.98% | $252.39 | 107K | Mar 29, 2022 | Direct | F6, F9 |
| Id | Content |
|---|---|
| F1 | This Form 4 amends and restates the previously reported sale transactions made by the Margaret C. Herbert 2018 Family Irrevocable GST Trust that occurred on March 29, 2022 in order to re-allocate such sales between three different sellers that are considered beneficially owned by the Reporting Person. |
| F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $250.00 to $250.78. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F3 | The amount of securities listed in Column 5 reflects the total shares held following the transaction owned by the Margaret C. Herbert 2018 Family Irrevocable GST Trust, by reference to the total reported in the Reporting Person's Form 4 filed on March 13, 2023. The total has increased from such Form 4 as a result of the prior overstatement of the sales by such trust on March 29, 2022 by 23,101 shares, which is corrected herein. |
| F4 | Shares held by the Margaret C. Herbert 2018 Family Irrevocable GST Trust. |
| F5 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $250.78 to $251.77. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F6 | The amount of securities listed in Column 5 reflects the total shares held following the transaction based on reference to the total reported in the Reporting Person's Form 4/A related to transactions originally reported on March 21, 2022 and that was filed on March 13, 2023. |
| F7 | Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust. |
| F8 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $251.85 to $252.10. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F9 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $252.10 to $252.935. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |